%PDF-1.4
%
1 0 obj
<>stream
application/pdf
10.1080/09537104.2020.1766670
Inflammatory state does not affect the antiplatelet efficacy of potent P2Y12 inhibitors in ACS
Benedikt S. Biesinger
Aleksandra Gasecka
Thomas Perkmann
Johann Wojta
Maciej Lesiak
Marek Grygier
Ceren Eyileten
Marek Postuła
Krzysztof J. Filipiak
Aurel Toma
Christian Hengstenberg
Jolanta M. Siller-Matula
Taylor & Francis
Platelets, 2020. doi:10.1080/09537104.2020.1766670
Acute Coronary Syndrome
inflammation
platelet Reactivity
prasugrel
statin
ticagrelor
en
Journal
Platelets
© 2020 Taylor & Francis Group, LLC
0953-7104
1369-1635
00
00
1
9
10.1080/09537104.2020.1766670
https://doi.org/10.1080/09537104.2020.1766670
VoR
application/pdfdoi:10.1080/09537104.2020.176667010.1080/09537104.2020.1766670https://doi.org/10.1080/09537104.2020.17666702020-06-05truewww.tandfonline.com10.1080/09537104.2020.1766670www.tandfonline.comtrue2020-06-0510.1080/09537104.2020.1766670
endstream
endobj
4 0 obj
<>stream
xˎ$_Q?YTz 3Ars2@OI< K~?$EJ,5]%ߤ_.a;1:_~ᰄRRv'c-K[~!uŘZk.oއ|
p>K
<>@7|^C1܊Os))9^Nc/>qyK(Z mI
3!sӒ